Evaluation of one year immunity following rabies post-exposure prophylaxis in dog bite cases.

IF 6.9 1区 医学 Q1 IMMUNOLOGY
Nisa Ya, Heidi Auerswald, Sothy Touch, Saraden In, Chanvannak Yun, Pisey Thai, Sotheary Sann, Borita Heng, Chanthy Leng, Veasna Duong, Yik Sing Peng, Sowath Ly, Tineke Cantaert
{"title":"Evaluation of one year immunity following rabies post-exposure prophylaxis in dog bite cases.","authors":"Nisa Ya, Heidi Auerswald, Sothy Touch, Saraden In, Chanvannak Yun, Pisey Thai, Sotheary Sann, Borita Heng, Chanthy Leng, Veasna Duong, Yik Sing Peng, Sowath Ly, Tineke Cantaert","doi":"10.1038/s41541-024-01030-8","DOIUrl":null,"url":null,"abstract":"<p><p>Rabies remains a global health threat despite being preventable with post-exposure prophylaxis (PEP). This study assessed one-year humoral and T cell immunity in PEP recipients of the Insitut Pasteur du Cambodge (IPC) regimen, recommended by WHO. We analyzed rabies virus (RABV) neutralizing antibodies (nAbs) and T cell responses at baseline, 7 and 14 days, 6 and 12 months after PEP. A total of 148 patients were included, with 78 bitten by confirmed RABV-positive dogs receiving PEP and equine rabies immunoglobulins (eRIG), and 70 bitten by RABV-negative dogs receiving only PEP. Fourteen days after PEP, all but two individuals seroconverted for nAbs ( ≥ 0.5 IU/mL) with 87% maintaining this response even after 12 months. Interleukin-4 (IL-4) and interferon-gamma (IFN-γ)-secreting T cells were significantly elevated after 14 days and sustained for one year. No differences were observed between the RABV-exposed and -unexposed groups. This study demonstrates robust one-year immunity after IPC PEP.</p>","PeriodicalId":19335,"journal":{"name":"NPJ Vaccines","volume":"9 1","pages":"237"},"PeriodicalIF":6.9000,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11603308/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41541-024-01030-8","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Rabies remains a global health threat despite being preventable with post-exposure prophylaxis (PEP). This study assessed one-year humoral and T cell immunity in PEP recipients of the Insitut Pasteur du Cambodge (IPC) regimen, recommended by WHO. We analyzed rabies virus (RABV) neutralizing antibodies (nAbs) and T cell responses at baseline, 7 and 14 days, 6 and 12 months after PEP. A total of 148 patients were included, with 78 bitten by confirmed RABV-positive dogs receiving PEP and equine rabies immunoglobulins (eRIG), and 70 bitten by RABV-negative dogs receiving only PEP. Fourteen days after PEP, all but two individuals seroconverted for nAbs ( ≥ 0.5 IU/mL) with 87% maintaining this response even after 12 months. Interleukin-4 (IL-4) and interferon-gamma (IFN-γ)-secreting T cells were significantly elevated after 14 days and sustained for one year. No differences were observed between the RABV-exposed and -unexposed groups. This study demonstrates robust one-year immunity after IPC PEP.

狗咬伤病例暴露后狂犬病预防后一年免疫力评估。
尽管暴露后预防(PEP)可以预防狂犬病,但狂犬病仍然是全球健康的威胁。本研究评估了接受世界卫生组织推荐的柬埔寨巴斯德研究所(IPC)方案的 PEP 受试者一年的体液免疫和 T 细胞免疫情况。我们分析了狂犬病病毒 (RABV) 中和抗体 (nAbs) 和 T 细胞在 PEP 后基线、7 天和 14 天、6 个月和 12 个月的反应。我们共纳入了 148 名患者,其中 78 人被确诊为 RABV 阳性的狗咬伤,接受了 PEP 和马狂犬病免疫球蛋白 (eRIG),70 人被 RABV 阴性的狗咬伤,只接受了 PEP。PEP 14 天后,除两人外,其他所有人都出现了 nAbs 血清转换(≥ 0.5 IU/mL),其中 87% 的人在 12 个月后仍能保持这种反应。分泌白细胞介素-4(IL-4)和γ干扰素(IFN-γ)的 T 细胞在 14 天后显著升高,并持续一年。在接触过 RABV 和未接触过 RABV 的组别之间未观察到差异。这项研究证明了 IPC PEP 一年后的强大免疫力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
NPJ Vaccines
NPJ Vaccines Immunology and Microbiology-Immunology
CiteScore
11.90
自引率
4.30%
发文量
146
审稿时长
11 weeks
期刊介绍: Online-only and open access, npj Vaccines is dedicated to highlighting the most important scientific advances in vaccine research and development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信